期刊文献+

曼月乐治疗他莫西芬所致的子宫内膜增生1例并文献复习 被引量:1

下载PDF
导出
摘要 目的:研究左炔诺孕酮宫内缓释系统(LNG-IUS)对服用他莫西芬(TAM)的乳腺癌患者的子宫内膜保护的有效性及安全性。方法:通过报道一例40岁T2N1M0(IIb期)乳腺癌,服用TAM后出现内膜增生,宫内放置LNG-IUS治疗成功,同时复习文献,分析在服用TAM的乳腺癌患者中,LNG-IUS对子宫内膜病变(子宫内膜增生、息肉、内膜癌)的预防作用及带来的风险。结果:文献报道均支持宫内放置LNG-IUS能降低内膜息肉的发生,但对内膜增生及内膜癌是否有预防作用尚无明确的证据支持;LNG-IUS是否诱发乳腺癌或增加乳腺癌的复发,文献报道不一。结论:LNG-IUS对TAM导致的内膜息肉有一定的保护作用,但其对内膜增生及内膜癌的预防、是否增加乳腺癌发病/复发风险还需要进一步的研究证实。
出处 《甘肃医药》 2015年第9期705-707,共3页 Gansu Medical Journal
  • 相关文献

参考文献14

  • 1Polin SA, Ascher SM. The effect of tamoxifen on the genital tract[J]. Cancer Imaging, 2008, 8( 1 ):135-145.
  • 2ACOG committee opinion No. 601 :Tamoxifen and uterine cancer[J]. Obstet Gynecol , 2014,123(6):1394-1397.
  • 3. van Leeuwen FE, Benraadt J, Coebergh JW, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer [J]. Lancet, 1994,343 (8895):448-52.
  • 4Chen JY, kuo SJ, Liaw YP, et al. Endometrial Cancer Incidence in Breast Cancer Patients Correlating with Age and Duration of Tamoxifen Use: a Population Based Study [J]. Journal of Cancer, 2014, 5(2):151-155.
  • 5Early Breast Cancer Trialists" Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast eaneer on reeurrenee and 15-year survival: an overview of the randomised trials[J].Laneet,2005, 365(9472):1687-717.
  • 6高雨农,蒋国庆.释放左旋18甲基炔诺酮宫内节育器对三苯氧胺引起子宫内膜病变的治疗[J].中国妇产科临床杂志,2004,5(5):359-362. 被引量:10
  • 7Kesim MD , Audin Y , Atis A , et al. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast patients taking tamoxifen[J].Climacteric, 2008,11 (3):252-257.
  • 8Gardner FJ, Konje JC, Abrams KR, et al. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial [J ].Gynecol Oncol, 2009,114( 3 ):452-456.
  • 9Chan SS, Tam WH, Yu MM, et al. A randomized controlled trial of prophylactic levonorgestril intrauterine system in tamoxifen-treated women[J].BJOG, 2007,114( 12 ):1510-1515.
  • 10Wong AW, Chan SS, Yeo W, et al. Prophylactic use of levonorgestrel- releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial [J]. Obstet Gynecol, 2013,121(5): 943-950.

二级参考文献19

  • 1李书娴,高淑华.绝经后阴道出血患者诊断性刮宫前B超检测子宫内膜的价值[J].中华妇产科杂志,1997,32(1):31-33. 被引量:136
  • 2[1]Love RR,Mazess RB,Barden HS,et al.Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.N Engl J Eed,1992,326:852-856.
  • 3[2]Love RR,Wieve DA,Newcomb PA,et al.Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.Ann Intern Med,1991,115:860-864.
  • 4[3]Cohen I.Endometrial pathologies associated with postmenopausal tamoxifen treatment.Gynecol Oncol,2004,94:256-266.
  • 5[4]Hann LE,Kim CM,Gonen M,et al.Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.Obstet Gynecol Surv,2004,59:440-441.
  • 6[5]Slomovitz BM,Sun CC,Ramirez PT,et al.Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer? Obstet Gynecol,2004,104:255-260.
  • 7[6]Panay N,Studd J.Progestogen intolerance and compliance with hormone replacement therapy in menopausal women.Hum Reprod Updme,1997,3:159-171.
  • 8[8]Nilsson CG,Haukkamaa M,Vierola H,et al.Tissue concentrations of levonorgestrel in women using levonorgestrel-releasing IUD.Clin Endocrinol,1982,17:529-536.
  • 9[9]Liane D,Tamara K,Carmel J,et al.Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.Gynecologic Oncology,2000,78:181-186.
  • 10[10]Deligdisch L,Kalir T,Cohen CJ,et al.Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.Gynecol Oncol,2000,78:181-186.

共引文献9

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部